Esha Gangolli
About Esha Gangolli
Esha Gangolli serves as the Executive Director of Clinical Research Science at Nimbus Therapeutics, bringing extensive experience in clinical research and translational medicine. She holds a Ph.D. in Cell Biology from Baylor College of Medicine and has held various leadership roles in the biotechnology and pharmaceutical sectors.
Current Role at Nimbus Therapeutics
Esha Gangolli serves as the Executive Director of Clinical Research Science at Nimbus Therapeutics. She has held this position since 2022 in Cambridge, Massachusetts. In her current role, she focuses on advancing clinical research initiatives and overseeing the development of innovative therapeutic solutions.
Previous Experience at Nimbus Therapeutics
Prior to her current role, Esha Gangolli worked as the Senior Director of Clinical Research Science at Nimbus Therapeutics from 2021 to 2022. During her tenure, she contributed to the organization's clinical research strategies and supported the transition of research findings into clinical applications.
Education and Expertise
Esha Gangolli holds a Ph.D. in Cell Biology from Baylor College of Medicine and an M.Sc. in Biotechnology from Savitribai Phule Pune University. She also earned a B.Sc. in Microbiology from the same university. Her educational background supports her expertise in translational medicine and the development of antisense oligonucleotide therapeutics.
Professional Background
Esha Gangolli has a diverse professional background in clinical research and academia. She has held various positions, including Senior Research Fellow at the University of Washington, Research Scientist at CuraGen Corporation, and several leadership roles at AstraZeneca, Clovis Oncology, and iTeos Therapeutics. Her experience spans over two decades in the field.
Committee Involvement
Esha Gangolli served as a member of the Finance Committee for the Town of Acton, MA, from 2020 to 2023. In this role, she participated in financial planning and decision-making processes, contributing her expertise to local governance.